Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease
Year: 2019
Type: review
Abstract: Obesity and associated liver diseases (Non Alcoholic Fatty Liver Disease, NAFLD) are a major public health problem with increasing incidence in Western countries (25% of the affected population). These complications develop from a fatty liver (steatosis) to an inflammatory state (steatohepatitis) evolving toward fibrosis and hepatocellular carcinoma. Lipid accumulation in the liver contributes to hepatocyte cell death and promotes liver injury. Local immune cells are activated either by Danger Associated Molecular Patterns (DAMPS) released by dead hepatocytes or by bacterial products (PAMPS) reaching the liver due to increased intestinal permeability. The resulting low-grade inflammatory state promotes the progression of liver complications toward more severe grades. Innate lymphoid cells (ILC) are an heterogeneous family of five subsets including circulating Natural Killer (NK) cells, ILC1, ILC2, ILC3, and lymphocytes tissue-inducer cells (LTi). NK cells and tissue-resident ILCs, mainly located at epithelial surfaces, are prompt to rapidly react to environmental changes to mount appropriate immune responses. Recent works have demonstrated the interplay between ILCs subsets and the environment within metabolic active organs such as liver, adipose tissue and gut during diet-induced obesity leading or not to hepatic abnormalities. Here, we provide an overview of the newly roles of NK cells and ILC1 in metabolism focusing on their contribution to the development of NAFLD. We also discuss recent studies that demonstrate the ability of these two subsets to influence tissue-specific metabolism and how their function and homeostasis are affected during metabolic disorders.
Source: Frontiers in Immunology
Authors: Carmelo Luci, Elodie Vieira, Thibaut Perchet, Philippe Gual, Rachel Golub
Language: English
Topic: IL-33, ST2, and ILC Pathways
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: non-alcoholic fatty liver disease, natural killer cells, type 1 innate lymphoid cells, ILC1, innate lymphoid cells, obesity, hepatic steatosis, steatohepatitis, liver fibrosis, hepatocellular carcinoma, damage-associated molecular patterns, PAMPS, intestinal permeability, tissue-specific metabolism, metabolic disorders, gut-liver axis
Open Access status: gold
Estimated APC paid: $2,950
Awards: INTERACTION BETWEEN ALCOHOL AND OBESITY IN THE SEVERITY OF FATTY LIVER DISEASE, G3360056500, Study of the SYK signaling pathway in chronic inflammatory diseases, G3693981238, G5094003450, Contribution of ILC and CD8 to Non-Alcoholic SteatoHepatitis and progression towards hepatocarcinoma, Réseau d'Innovation sur les Voies de Signalisation en Sciences de la Vie, G8800819381, G880779785
OpenAlex ID: W2947361176
